There is an evidence that CB2 activation has beneficial effects in animal models of chronic degenerative diseases, such as atherosclerosis [17, 28] and liver fibrosis [37, 41, 42], by reducing inflammatory, oxidative, and fibrotic processes. This evidence concerns the gene CNR2 and atherosclerosis.